Search All News
A new brain cancer study is testing an ultrasound technology developed at Columbia to determine if the technology can open the blood-brain barrier and improve delivery of chemotherapy.
Even a brief exposure to addictive medications for surgery-related pain or anxiety can lead to long-term use, a study by Columbia researchers has found.
New guidelines encourage initial screening for colorectal cancer at 45 instead of 50, because younger people are increasingly being diagnosed with the disease, says Columbia's James Church, MD.
Opinions vary about how to treat DCIS (ductal carcinoma in situ), but a new study suggests the optimal treatment for most women with this non-invasive breast cancer is surgery plus radiation.
- October 31, 2018
A new study found that women with cervical cancer who had a radical hysterectomy with minimally invasive surgery had a significantly higher risk of death than those who had open surgery.
- October 12, 2018
For the second year, Velocity, Columbia's Ride to End Cancer raised more than $1 million for cancer care and research.
- September 28, 2018
Sarah Urke and Barbara Trencher, Columbia physical therapists and Velocity participants, developed an exercise program for cancer patients.
- September 20, 2018
Leaders in prostate cancer research and care will convene Sept. 22 for the inaugural NYC Prostate Cancer Summit, a patient-focused event co-hosted by CUIMC and NewYork-Presbyterian.
- August 27, 2018
Physician-scientist Darrell Yamashiro, MD, PhD, has been named director of Columbia's Division of Pediatric Hematology, Oncology, & Stem Cell Transplantation.
- July 30, 2018
Columbia researchers found that a gene associated with an autoimmune form of hair loss could be activated to improve cancer immunotherapy.
- July 10, 2018
Acupuncture significantly eased joint pain for a majority of women undergoing a common form of breast cancer treatment, a new study found.
- July 5, 2018
A very low carbohydrate, high-fat diet called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, according to a study in mice.
- June 29, 2018
Cell-based therapy expert Pawel Muranski, MD, discusses the challenges of testing cancer immunotherapy drugs in new patient groups.